4.14
price down icon1.19%   -0.05
after-market アフターアワーズ: 4.16 0.02 +0.48%
loading
前日終値:
$4.19
開ける:
$4.18
24時間の取引高:
204.89K
Relative Volume:
0.33
時価総額:
$91.40M
収益:
-
当期純損益:
$-94.11M
株価収益率:
-0.6889
EPS:
-6.01
ネットキャッシュフロー:
$-86.06M
1週間 パフォーマンス:
-3.50%
1か月 パフォーマンス:
-7.38%
6か月 パフォーマンス:
+82.38%
1年 パフォーマンス:
-28.00%
1日の値動き範囲:
Value
$4.14
$4.19
1週間の範囲:
Value
$4.14
$4.2848
52週間の値動き範囲:
Value
$1.78
$6.98

Adverum Biotechnologies Inc Stock (ADVM) Company Profile

Name
名前
Adverum Biotechnologies Inc
Name
セクター
Healthcare (1129)
Name
電話
(650) 649-1004
Name
住所
100 CARDINAL WAY, REDWOOD CITY, CA
Name
職員
155
Name
Twitter
@adverumbio
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
ADVM's Discussions on Twitter

ADVM を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ADVM
Adverum Biotechnologies Inc
4.14 92.50M 0 -94.11M -86.06M -6.01
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.76 107.15B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
755.90 77.46B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
436.38 58.90B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
918.92 56.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
198.76 42.58B 447.02M -1.18B -906.14M -6.1812

Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-11-17 ダウングレード H.C. Wainwright Buy → Neutral
2024-06-25 開始されました Oppenheimer Outperform
2024-04-30 開始されました H.C. Wainwright Buy
2022-07-07 アップグレード Truist Hold → Buy
2021-07-23 ダウングレード Cantor Fitzgerald Overweight → Neutral
2021-05-03 ダウングレード SVB Leerink Outperform → Mkt Perform
2021-04-29 ダウングレード Chardan Capital Markets Buy → Neutral
2021-04-29 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2021-04-29 ダウングレード Truist Buy → Hold
2020-12-16 開始されました UBS Neutral
2020-11-12 アップグレード Raymond James Underperform → Mkt Perform
2020-06-26 ダウングレード Raymond James Mkt Perform → Underperform
2020-05-13 開始されました RBC Capital Mkts Outperform
2020-05-05 アップグレード SunTrust Hold → Buy
2020-04-28 開始されました Goldman Buy
2020-03-16 開始されました SVB Leerink Outperform
2020-02-10 アップグレード Cantor Fitzgerald Neutral → Overweight
2020-02-10 アップグレード Chardan Capital Markets Neutral → Buy
2019-10-15 繰り返されました Chardan Capital Markets Neutral
2019-09-13 繰り返されました Chardan Capital Markets Neutral
2019-06-14 再開されました Raymond James Mkt Perform
2018-11-02 ダウングレード Raymond James Outperform → Mkt Perform
2018-11-02 ダウングレード SunTrust Buy → Hold
2018-09-21 開始されました Cantor Fitzgerald Overweight
2018-08-30 開始されました SunTrust Buy
2018-02-15 再開されました Piper Jaffray Overweight
2017-10-12 開始されました Raymond James Outperform
すべてを表示

Adverum Biotechnologies Inc (ADVM) 最新ニュース

pulisher
04:44 AM

Adverum Biotechnologies Faces Lease Termination Notice - TipRanks

04:44 AM
pulisher
04:05 AM

Adverum Biotechnologies IncARE-NC Region No. 21 LLC terminates certain lease agreement with Adverum BiotechnologiesSEC filing - MarketScreener

04:05 AM
pulisher
05:10 AM

Chart overlay techniques for tracking Adverum Biotechnologies Inc.2025 Price Targets & Low Risk Growth Stock Ideas - newser.com

05:10 AM
pulisher
04:22 AM

Is Adverum Biotechnologies Inc. stock cheap compared to fundamentals2025 Retail Activity & Weekly High Momentum Picks - newser.com

04:22 AM
pulisher
04:05 AM

Lilly strengthens gene therapy portfolio with MeiraGTx and Adverum deals - Drug Discovery News

04:05 AM
pulisher
Nov 20, 2025

Why Adverum Biotechnologies Inc. stock remains on watchlistsJuly 2025 Levels & Weekly High Conviction Ideas - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why Adverum Biotechnologies Inc. (AVU0) stock trades below fair valueJuly 2025 Action & Risk Managed Trade Strategies - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Adverum Biotechnologies Inc. stock maintain growth storyMarket Growth Report & Safe Swing Trade Setups - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Why retail traders accumulate Adverum Biotechnologies Inc. (AVU0) stockQuarterly Risk Review & Low Drawdown Trading Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Has Adverum Biotechnologies Inc. found a price floor2025 Risk Factors & Low Risk High Reward Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Volume spikes in Adverum Biotechnologies Inc. stock – what they mean2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Adverum Biotechnologies Inc. (AVU0) stock benefit from mergersJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

The Zacks Analyst Blog Highlights Eli Lilly, Johnson & Johnson and Adverum - sharewise.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 05:22:39 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Adverum Biotechnologies Inc. stock deliver consistent dividends2025 Support & Resistance & Long-Term Growth Stock Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-18 23:52:15 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why analysts maintain buy rating on Adverum Biotechnologies Inc. (AVU0) stockWatch List & Target Return Focused Picks - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Halper Sadeh LLC Encourages CMA, ADVM, HOUS Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.

Nov 18, 2025
pulisher
Nov 17, 2025

This Yum! Brands Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - Benzinga

Nov 17, 2025
pulisher
Nov 17, 2025

This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Nov 17, 2025
pulisher
Nov 17, 2025

HC Wainwright Downgrades Adverum Biotechnologies to Neutral From Buy, Adjusts PT to $5 From $30 - MarketScreener

Nov 17, 2025
pulisher
Nov 17, 2025

H.C. Wainwright downgrades Adverum stock to Neutral following Eli Lilly acquisition - Investing.com Canada

Nov 17, 2025
pulisher
Nov 17, 2025

This Dell Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday - Benzinga

Nov 17, 2025
pulisher
Nov 17, 2025

HC Wainwright Downgrades Adverum Biotechnologies to Neutral From Buy, Price Target is $5 - MarketScreener

Nov 17, 2025
pulisher
Nov 16, 2025

Detecting price anomalies in Adverum Biotechnologies Inc. with AIWeekly Stock Analysis & AI Enhanced Market Trend Forecasts - newser.com

Nov 16, 2025

Adverum Biotechnologies Inc (ADVM) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$38.92
price up icon 1.38%
$30.45
price up icon 1.36%
$102.06
price up icon 0.29%
$95.59
price down icon 1.42%
biotechnology ONC
$347.72
price down icon 0.45%
$198.76
price down icon 0.44%
大文字化:     |  ボリューム (24 時間):